News

Myriad Genetics downgraded to Neutral from Buy at Guggenheim
Guggenheim downgraded Myriad Genetics (MYGN) to Neutral from Buy without a price target Based on key opinion leader checks on GeneSight and ...
Myriad Genetics Announces Inducement Awards
About Myriad Genetics Myriad Genetics is a leading molecular diagnostics testing and precision medicine company dedicated to advancing health and well-being for all. Myriad Genetics develops and ...
Yahoo Finance3d
Myriad Genetics Names Brian Donnelly as New Chief Commercial Officer
Myriad Genetics, Inc. SALT LAKE CITY, April 07, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics testing and precision medicine, announced today the ...